Vibrating lung device tested in hip fracture patients

NCT ID NCT07517497

Disease control Sponsor: Astana Medical University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a special vibrating device placed on the chest can improve breathing in older patients with a hip fracture who also have respiratory failure. 60 participants will receive the therapy for 5 days, and doctors will check their blood oxygen levels and lung X-rays. The goal is to see if this device helps manage lung complications without needing active effort from the patient.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

* respiratory failure; * hip fracture; * Injury Severity Score no higher than 8 points. Exclusion Criteria: * All contraindications for use of the device: * terminal condition of the patient; * shock; * paradoxical pathological breathing; * hypertensive crisis; * severe hypocoagulation with a risk of hematoma formation or bleeding in the projection of exposure; * severe hypercoagulation, risk of thrombus/embolus migration along the main vessels in the area of exposure; * acute cerebrovascular accident in the first 1-3 days; * brain edema; * presence of multiple purulent or burn wound surfaces in the area of exposure; * presence of unstable rib fractures; * pneumomediastinum and/or subcutaneous emphysema of the chest; * osteomyelitis of the ribs and/or thoracic spine; * spinal fracture without orthopedic fixation; * chest or abdominal trauma with bleeding; * Injury Severity Score greater than 8 points; * concomitant diseases in the stage of decompensation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute respiratory failure in geriatric patients with hip fracture are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute respiratory failure hip fracture

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Respiratory complications Vibration

How to take part

Only the study team decides who joins. These are the ways to reach them.

The places running it

1 site. The list below names each one and where it is.
The official record

ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

Open the record ↗
A doctor treating you

A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Vibrating lung device tested in hip fracture patients

What the study statuses mean